Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus QFIN Q4 2025 Earnings Slight EPS Miss Amid Positive Stock Reaction VET Q1 2026 Earnings Significant EPS Miss With Flat Market Reaction BGS Q1 2026 Earnings Earnings Beat Estimates by 457 as Bottom Line Exceeds Expectations AMPGR Q1 2026 Earnings EPS Miss of 1765 Triggers Stock Decline OXLCN Q4 2025 Earnings Preferred Stock Reports Slight EPS Miss Amid Steady Portfolio Performance